Many people taking INGREZZA 80 mg in a clinical study started to see improvements in as little as 2 weeks,* and 7 out of 10 people had reduced movements at 6 weeks.† *INGREZZA was studied in a 6-week clinical trial. A total of 234 people participated in the study. Results were based on 79 people taking the recommended dose of 80 mg. †Patients had at least a 1-point reduction on an uncontrollable movement severity scale at 6 weeks vs before treatment. This post-clinical study evaluation included 70 patients taking INGREZZA 80 mg, measuring uncontrollable movements before starting treatment and at 6 weeks of treatment. Learn more about INGREZZA